Marchou B - Search Results

1

Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine.

Izopet J, Bicart-See A, Pasquier C, Sandres K, Bonnet E, Marchou B, Puel J, Massip P. Izopet J, et al. Among authors: marchou b. J Med Virol. 1999 Dec;59(4):507-11. J Med Virol. 1999. PMID: 10534734 Clinical Trial.

2

Quantification of HIV-1 proviral DNA by a standardized colorimetric PCR-based assay.

Izopet J, Tamalet C, Pasquier C, Sandres K, Marchou B, Massip P, Puel J. Izopet J, et al. Among authors: marchou b. J Med Virol. 1998 Jan;54(1):54-9. doi: 10.1002/(sici)1096-9071(199801)54:1<54::aid-jmv8>3.0.co;2-o. J Med Virol. 1998. PMID: 9443109 Clinical Trial.

3

Decay of HIV-1 DNA in patients receiving suppressive antiretroviral therapy.

Izopet J, Salama G, Pasquier C, Sandres K, Marchou B, Massip P, Puel J. Izopet J, et al. Among authors: marchou b. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 15;19(5):478-83. doi: 10.1097/00042560-199812150-00006. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9859961

4

Intermittent selection pressure with zidovudine plus zalcitabine treatment reduces the emergence in vivo of zidovudine resistance HIV mutations.

Izopet J, Sailler L, Sandres K, Pasquier C, Bonnet E, Aquilina C, Puel J, Massip P, Marchou B. Izopet J, et al. Among authors: marchou b. J Med Virol. 1999 Feb;57(2):163-8. J Med Virol. 1999. PMID: 9892402 Clinical Trial.

5

Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen.

Izopet J, Massip P, Souyris C, Sandres K, Puissant B, Obadia M, Pasquier C, Bonnet E, Marchou B, Puel J. Izopet J, et al. Among authors: marchou b. AIDS. 2000 Oct 20;14(15):2247-55. doi: 10.1097/00002030-200010200-00005. AIDS. 2000. PMID: 11089612

6

Minority variants associated with resistance to HIV-1 nonnucleoside reverse transcriptase inhibitors during primary infection.

Nicot F, Saliou A, Raymond S, Sauné K, Dubois M, Massip P, Marchou B, Delobel P, Izopet J. Nicot F, et al. Among authors: marchou b. J Clin Virol. 2012 Oct;55(2):107-13. doi: 10.1016/j.jcv.2012.06.018. Epub 2012 Jul 20. J Clin Virol. 2012. PMID: 22818969

7

Evolution of total and integrated HIV-1 DNA and change in DNA sequences in patients with sustained plasma virus suppression.

Izopet J, Cazabat M, Pasquier C, Sandres-Sauné K, Bonnet E, Marchou B, Massip P, Puel J. Izopet J, et al. Among authors: marchou b. Virology. 2002 Oct 25;302(2):393-404. doi: 10.1006/viro.2002.1621. Virology. 2002. PMID: 12441083 Free article.

8

Assessment of a standardized reverse-transcriptase PCR assay for quantifying HIV-1 RNA in plasma and serum.

Izopet J, Poggi C, Dussaix E, Mansuy JM, Cubaynes L, Profizi N, Lafeuillade A, Marchou B, Massip P, Sayada C, Puel J. Izopet J, et al. Among authors: marchou b. J Virol Methods. 1996 Jul;60(2):119-29. doi: 10.1016/0166-0934(96)02019-8. J Virol Methods. 1996. PMID: 8844617

9

Lipodystrophia with protease inhibitors in HIV patients.

Massip P, Marchou B, Bonnet E, Cuzin L, Montastruc JL. Massip P, et al. Among authors: marchou b. Therapie. 1997 Nov-Dec;52(6):615. Therapie. 1997. PMID: 9734120 No abstract available.

10

Increased incidence of indinavir nephrolithiasis in patients with hepatitis B or C virus infection.

Malavaud B, Dinh B, Bonnet E, Izopet J, Payen JL, Marchou B. Malavaud B, et al. Among authors: marchou b. Antivir Ther. 2000 Mar;5(1):3-5. Antivir Ther. 2000. PMID: 10846585

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters